Exam RAC-US Topic 1 Question 52 Discussion
Actual exam question for RAPS's RAC-US exam
Question #: 52
Topic #: 1
Question #: 52
Topic #: 1
A protocol for a pivotal registration trial of a new product is submitted to a major regulatory authority for review and approval. The regulatory authority issues the company a written commitment that if the studies are completed as outlined in the protocol and the results meet the pre-specified criteria for efficacy and safety, the product will be approved.
During the final week of the review of the marketing application, which has fully met all pre- specified criteria, the company receives a letter from the regulatory authority stating that it no longer believes that the product will be approved based on a recent withdrawal of a similar product in another country.
What is the BEST response?
During the final week of the review of the marketing application, which has fully met all pre- specified criteria, the company receives a letter from the regulatory authority stating that it no longer believes that the product will be approved based on a recent withdrawal of a similar product in another country.
What is the BEST response?
Suggested Answer: A Vote an answer
by Aurora at Nov 30, 2024, 07:22 AM
Contact Us
If you have any question please leave me your email address, we will reply and send email to you in 12 hours.
Our Working Time: ( GMT 0:00-15:00 ) From Monday to Saturday
Support: Contact now
Comments
Upvoting a comment with a selected answer will also increase the vote count towards that answer by one. So if you see a comment that you already agree with, you can upvote it instead of posting a new comment.
Report Comment
Commenting
You can sign-up / login (it's free).